弥散加权MRI与18F-FDG PET在BNL肝细胞癌小鼠模型中与放射治疗早期免疫反应的时序验证
本研究在BNL原位肝细胞癌小鼠模型中,于15 Gy照射前后纵向进行T2加权MRI、弥散加权MRI和18F-FDG PET扫描,评估肿瘤早期放疗反应。结果显示照射后第1天ADC值即升高,18F-FDG摄取持续增加至观察期末,免疫组化证实增殖细胞减少和巨噬细胞持续浸润。ADC值和18F-FDG摄取可作为肝细胞癌放疗早期疗效评估的潜在生物标志物。
要点
- 照射后第1天ADC值即升高,可作为早期放疗反应指标
- 18F-FDG摄取在照射后第1天增加并持续至观察期末
- 肿瘤微环境中巨噬细胞浸润与18F-FDG摄取增加相关
核心结论
- DW MRI测得的ADC值和18F-FDG PET测得的摄取可作为肝细胞癌放疗早期疗效评估的潜在生物标志物。
研究设计与样本
- 在Balb/c小鼠右肝叶建立原位肝细胞癌肿瘤模型,对右肝叶给予15 Gy照射。
- 照射前1天及照射后第1、3、6、9、13天纵向进行T2加权MRI、弥散加权MRI和18F-FDG PET扫描,测定肿瘤大小、ADC值和最大标准化摄取值。
- 采用免疫组化染色验证肿瘤微环境,并进行HCC细胞与巨噬细胞的体外共培养实验。
主要发现
- 照射明显延缓原位肝细胞癌模型的肿瘤生长。
- 照射后第1天ADC值即升高。
- 照射后第1天18F-FDG摄取增加,并持续至观察期末。
- 免疫组化显示照射肿瘤中增殖细胞数量减少,巨噬细胞持续浸润,肿瘤微环境发生显著改变。
- 体外共培养HCC细胞与巨噬细胞导致细胞间相互作用,并增强细胞对18F-FDG的摄取。
临床怎么用
- 对于接受放疗的肝细胞癌患者,可考虑联合DW MRI的ADC值和18F-FDG PET摄取进行早期疗效评估。
- 解读18F-FDG PET早期摄取增高时需考虑巨噬细胞浸润等肿瘤微环境改变的影响。
局限性
- 本研究为BNL肝细胞癌小鼠模型,结果外推至临床患者需进一步验证。
- 原文未报告样本量、具体统计值和P值等详细数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Imaging probes/biomarkers that are correlated with molecular or microenvironmental alterations in tumors have been used not only in diagnosing cancer but also in assessing the efficacy of cancer treatment. We evaluated the early response of hepatocellular carcinoma (HCC) to radiation treatment using T2-weighted magnetic resonance imaging (MRI), diffusion-weighted (DW) MRI, and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET). METHODS: Orthotopic HCC tumors were established in the right liver lobe of Balb/c mice. Mice were longitudinally scanned using T2-weighted/DW MRI and 18F-FDG PET 1 day before and on days 1, 3, 6, 9 and 13 after irradiation with 15 Gy to the right liver lobe to determine tumor size, apparent diffusion coefficient (ADC) value, and maximum standardized uptake value. Immunohistochemical (IHC) staining was performed to validate the tumor microenvironment. RESULTS: Irradiation markedly retarded tumor growth in the orthotopic HCC model and led to increaes in ADC values as early as on day 1 after irradiation. Irradiation also resulted in increases in 18F-FDG uptake on day 1 that were sustained until the end of the observation period. IHC staining revealed a decrease in the number of proliferative cells and a continuous macrophage influx into irradiated tumors, which dramatically altered the tumor microenvironment. Lastly, in vitro coculture of HCC cells and macrophages led to interaction between the cells and enhanced the cellular uptake of 18F-FDG. CONCLUSION: ADC values and 18F-FDG uptake measured using DW MRI and 18F-FDG PET serve as potential biomarkers for early assessment of HCC tumor responses to radiation therapy.
引用
- Chung YH, Yu CF, Chiu SC, et al. Diffusion-weighted MRI and 18F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation. Eur J Nucl Med Mol Imaging. 2019. PMID: 31127350. doi:10.1007/s00259-019-04318-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。